MedPath

Evaluation of the Impact of 3 Methods of Communication on the Adherence of Methotrexate in Patients With Rheumatoid Arthritis

Not Applicable
Conditions
Polyarthritis; Rheumatoid
Methotrexate
Interventions
Other: Communication methods to encourage adherence
Registration Number
NCT03107299
Lead Sponsor
Centre Hospitalier Universitaire, Amiens
Brief Summary

Methotrexate (MTX) is the first-line treatment for rheumatoid arthritis (RA). Poor adherence of this treatment decreases the control of the disease and the effectiveness of the associated treatments.

The aim would be to study the observance of patients with RA and to be able to propose adequate solutions favoring patient compliance and thus the stability of the pathology.

For this purpose, 3 methods of communication have been put in place to encourage adherence: usual care by the rheumatologist, sms sending or pharmaceutical maintenance.

Detailed Description

Not available

Recruitment & Eligibility

Status
UNKNOWN
Sex
All
Target Recruitment
150
Inclusion Criteria
  • Adult patients attending Day Hospital or consultation of rheumatology with rheumatoid polyarteritis and under treatment with MTX alone or in combination with another therapeutic, fixed dosage for at least 3 months.
  • Consenting Patient
  • Literate French-speaking patient,
  • Patient with a mobile phone
  • Patient affiliated to a social security scheme
Exclusion Criteria
  • Patient not managing his own treatment

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
pharmaceutical maintenance following medical consultationCommunication methods to encourage adherence-
ControlCommunication methods to encourage adherence-
Send sms to patientsCommunication methods to encourage adherence-
Primary Outcome Measures
NameTimeMethod
CQR19 (Compliance Questionnaire Rheumatology) Compliance Measurement Surveywith rheumatoid arthritis.10 months
Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

CHU Amiens Picardie

🇫🇷

Amiens, Picardie, France

© Copyright 2025. All Rights Reserved by MedPath